Erina Todd
About Erina Todd
Erina Todd is a Senior Clinical Research Associate with extensive experience in clinical research, currently holding multiple roles across various companies including Silk Road Medical, Inc., Calyxo, Inc., and Milestone Pharmaceuticals, Inc.
Current Roles
Erina Todd currently holds several positions as a Senior Clinical Research Associate at various companies. She is actively working with Silk Road Medical, Inc., Calyxo, Inc., and Milestone Pharmaceuticals, Inc. Alongside these roles, she also serves as the Owner/President of ELT Clinical Consulting, LLC in Strongsville, OH. Her concurrent roles demonstrate her capacity for multitasking and effective time management.
Previous Experience
Erina Todd has a rich history of clinical research experience. She worked with Cartiva, Inc. from 2017 to 2022, and Ferring from 2017 to 2019. At Aimmune Therapeutics, she was engaged from 2016 to 2022. She also contributed to Alvine Pharmaceuticals Inc for 10 months in 2014-2015 and to Abbott Vascular for 4 years, from 2013 to 2017. Notably, she held a short-term position at 1st Bio Sdn Bhd, representing Abbott Molecular, in 2022 for 5 months.
Clinical Research Responsibilities
In her career as a Senior Clinical Research Associate, Erina Todd has been responsible for a variety of tasks. These include conducting site initiation visits, interim-monitoring visits, and close-out visits. She also prepares for FDA audits and is responsible for training study protocols. Her diverse role across multiple companies highlights her expertise and adaptability in the field of clinical research.
Extensive Industry Background
Erina Todd brings extensive experience to the clinical research industry, having worked in both short-term and long-term roles across multiple companies. Her diverse background includes engagements with major firms such as Silk Road Medical, Inc., Calyxo, Inc., Milestone Pharmaceuticals, Inc., and several others. This breadth of experience has equipped her with a solid understanding of the clinical research landscape.